Irlanda - inglês - HPRA (Health Products Regulatory Authority)

baxter holding b.v. - sodium chloride; potassium chloride; calcium chloride dihydrate; sodium lactate - solution for infusion - 3.2 gram(s) - solutions affecting the electrolyte balance; electrolytes

Irlanda - inglês - HPRA (Health Products Regulatory Authority)

laboratoire aguettant - glucose - solution for infusion - solutions affecting the electrolyte balance; electrolytes with carbohydrates

Estados Unidos - inglês - NLM (National Library of Medicine)

bracco diagnostics inc - sulfur hexafluoride (unii: ws7lr3i1d6) (sulfur hexafluoride - unii:ws7lr3i1d6), distearoylphosphatidylcholine, dl- (unii: eag959u971) (distearoylphosphatidylcholine, dl- - unii:eag959u971), sodium 1,2-dipalmitoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (unii: 841b886ej7) (sodium 1,2-dipalmitoyl-sn-glycero-3-phospho-(1'-rac-glycerol) - unii:841b886ej7) - sulfur hexafluoride 60.7 mg in 1 mg - echocardiography lumason is indicated for use in adult and pediatric patients with suboptimal echocardiograms to opacify the left ventricular chamber and to improve the delineation of the left ventricular endocardial border. ultrasonography of the liver lumason is indicated for use with ultrasound of the liver in adult and pediatric patients to characterize focal liver lesions. ultrasonography of the urinary tract lumason is indicated for use in ultrasonography of the urinary tract in pediatric patients for the evaluation of suspected or known vesicoureteral reflux. lumason is contraindicated in patients with known or suspected: - hypersensitivity to sulfur hexafluoride lipid microsphere or its components, such as polyethylene glycol (peg) [see warnings and precautions (5.2) and description (11)] . risk summary there are no data with lumason use in pregnant women to inform any drug-associated risks. no adverse developmental outcomes were observed in animal reproduction studies with administration of sulfur he

Irlanda - inglês - HPRA (Health Products Regulatory Authority)

maco pharma (uk) ltd - sodium chloride calcium chloride dihydrate potassium chloride sodium lactate solution 60% - solution for infusion - 6/0.27/0.4 grams

Irlanda - inglês - HPRA (Health Products Regulatory Authority)

maco pharma (uk) ltd - sodium chloride calcium chloride dihydrate potassium chloride sodium lactate solution 60% - solution for infusion

Austrália - inglês - APVMA (Australian Pesticides and Veterinary Medicines Authority)

randlab australia pty ltd - pentosan polysulfate sodium - parenteral liquid/solution/suspension - pentosan polysulfate sodium mineral-sodium active 100.0 mg/ml - musculoskeletal system - dog | bitch | castrate | puppy - inflammatory joint disease | non-infectious joint disease

Malta - inglês - Medicines Authority

b braun melsungen ag carl-braun-strasse 1, d34212 melsungen, germany - calcium chloride, dihydrate, potassium chloride, sodium chloride, sodium lactate - solution for infusion - sodium chloride 6 g/l sodium lactate 3.12 g/l calcium chloride dihydrate 0.27 g/l potassium chloride 0.4 g/l - blood substitutes and perfusion solutions

Irlanda - inglês - HPRA (Health Products Regulatory Authority)

pharma regulatory solutions ltd - voriconazole - pdr for soln for infusion - 200 milligram - triazole derivatives - antimycotics for systemic use, triazole derivatives - voriconazole is a broad-spectrum, triazole antifungal agent and is indicated in adults and children aged 2 years and above as follows: treatment of invasive aspergillosis. treatment of candidaemia in non-neutropenic patients. treatment of fluconazole-resistant serious invasive candida infections (including c. krusei). treatment of serious fungal infections caused by scedosporium spp. and fusarium spp. voriconazole should be administered primarily to patients with progressive, possibly life-threatening infections. prophylaxis of invasive fungal infections in high risk allogeneic hematopoietic stem cell transplant (hsct) recipients.

Irlanda - inglês - HPRA (Health Products Regulatory Authority)

actavis group ptc ehf - voriconazole - powder for solution for infusion - 200 milligram(s) - voriconazole

Irlanda - inglês - HPRA (Health Products Regulatory Authority)

xellia pharmaceuticals aps - voriconazole - powder for solution for infusion - 200 milligram(s) - triazole derivatives; voriconazole